Myriad Genetics Inc (MYGN)

EBITDA Growth

91.75%

Quarterly · Period ending:

MYGN logo

MYGN EBITDA Growth

Year-over-year change vs the same period a year earlier

Latest reported91.75%
MYGN Quarterly EBITDA YoY % (-420.00% → 91.75%)
High-resolution chart · PNG

MYGN ebitda growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Myriad Genetics Inc EBITDA Growth — Quarterly
Period endingEBITDA Growth
91.746%
-23.2394%
134.322%
-104.1667%
-1,378.8732%
-46.3918%
-44.7853%
89.5879%
79.1789%
70.3364%
56.5333%
-52.1452%
-2,225%
-161.6%
-26.2626%
-154.9909%
-129.1391%
55.6738%
-264.0884%
338.5281%
140.0531%
74.5717%
94.6237%
-1,825%
-371.223%
-547.1774%
-62.8%
-105.6338%
-47.1483%
-7.4627%
28.866%
-78.1089%
-21.021%
19.6429%
-29.7101%
600%
-21.2766%
-54.8387%
-46.7181%
-72.2555%
-1.189%
17.8147%
22.4586%
57.0533%
-27.1733%
-28.3612%
-50.4904%
-62.5921%
-13.7715%
-2.2147%
47.7399%
67.8893%
37.4007%
24.172%
21.0947%
16.447%
13.6502%
10.9458%
18.2958%
16.7907%
10.7798%
24.6293%
11.344%
18.599%
-47.8136%
-7.075%
1.6656%
102.2803%
10.28%
781.2805%
642.8985%
263.6325%
767.5083%
22.5305%
-149.7916%
28.1583%
15.7592%
30.2823%
266.81%
-57.4673%
-69.2425%
-11.4292%
13.4588%
7.8962%
23.967%
5.3959%
-2.1574%
-4.3662%
-48.6024%
-101.5985%
-46.4157%
-83.1868%
-1.9407%
-48.9676%
-121.5342%
-148.1039%
-153.781%
-40.6693%
-19.6237%
17.8105%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.